ArticleslgStudy

chemistry

Mobocertinib

Mobocertinib is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Mobocertinib rather than just read about it. In short: Mobocertinib, sold under the brand name Exkivity, is used for the treatment of non-small cell lung cancer. The most common side effects include diarrhea, rash, nausea, stomatitis, vomiting, decreased appetite, paronychia, fatigue, dry skin, and musculoskeletal pain.

Mobocertinib — main illustration
Mobocertinib — illustration

Key takeaways

  • Mobocertinib belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Mobocertinib to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Mobocertinib from memory before moving on to harder problems.

Reference excerpt

Mobocertinib, sold under the brand name Exkivity, is used for the treatment of non-small cell lung cancer. The most common side effects include diarrhea, rash, nausea, stomatitis, vomiting, decreased appetite, paronychia, fatigue, dry skin, and musculoskeletal pain. Mobocertinib is a small molecule tyrosine kinase inhibitor structurally similar to osimertinib (differs only by the presence of an additional isopropyl ester group). Its molecular target is epidermal growth factor receptor (EGFR) bearing mutations in the exon 20 region. Mobocertinib is an irreversible kinase inhibitor, forming a covalent bond with the cysteine 797 in the EGFR active site, leading to sustained inhibition of EGFR enzymatic activity. The irreversible binding leads to increased potency via higher affinity binding, more sustained EGFR kinase activity inhibition, and greater overall selectivity, as only a limited number of other kinases possess a cysteine in the equivalent position. Mobocertinib was approved for medical use in the United States in September 2021. It is a first-in-class oral treatment to target EGFR Exon20 insertion mutations.

Medical uses Mobocertinib is indicated for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.

Mechanism of action Mobocertinib acts to inhibit EGFR exon 20 insertion mutations at a lower concentration than it does on wild-type proteins.

Pharmacokinetics The volume of distribution of Mobocertinib at steady state is 3,509 L. The mean oral bioavailability of Mobocertinib is 37%. The median Tmax is 4 hours. The average half-life of Mobocertinib and its metabolites is 18 hours. Mobocertinib is metabolized by CYP3A enzymes.

Warnings Mobocertinib may increase the chance of QTC prolongation, specifically Torsades de Pointes which can be fatal.

Adverse effects More serious side effects of Mobocertinib may include agitation, bloating of the eyes, lips, feet, blurred vision, coma, decreased urine output, headache, hostility, diarrhea, depression, dizziness, fainting, lethargy, anxiety, nausea, seizures, weight gain, fatigue as well as edema. Other side effects which may be less frequent are: chills, cough, dilated neck veins, ill-feeling and trouble with breathing. Other notable side effects of taking Mobocertinib are: having an acidic stomach, heartburn, acidity, hair loss/thinning, bone pain, sore throat, stuffy nose, trouble swallowing, vomiting and weakness in hands and feet.

History Mobocertinib was studied in participants with previously treated metastatic non-small cell lung cancer with EGFR exon 20 insertions. The FDA granted the application for mobocertinib orphan drug designation.

References

External links Clinical trial number NCT02716116 for "A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer" at ClinicalTrials.gov

Illustrations

Mobocertinib illustration

Worked examples

Example 1 — a first encounter with Mobocertinib

Start with the simplest possible case. Write down what Mobocertinib claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Mobocertinib before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Mobocertinib ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Mobocertinib

In research
Mobocertinib appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Mobocertinib in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Mobocertinib is common in secondary-school and first-year university syllabi. It links to neighbouring topics Amides, CYP3A4 inducers, Dimethylamino compounds, so understanding it makes those chapters shorter.
In everyday life
Look for Mobocertinib outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Mobocertinib” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Mobocertinib in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Mobocertinib means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Mobocertinib out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Mobocertinib in simple terms?

Mobocertinib, sold under the brand name Exkivity, is used for the treatment of non-small cell lung cancer. The most common side effects include diarrhea, rash, nausea, stomatitis, vomiting, decreased appetite, paronychia, fatigue, dry skin, and musculoskeletal pain.

Why does Mobocertinib matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Mobocertinib?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Mobocertinib.

Tags

  • Amides
  • CYP3A4 inducers
  • Dimethylamino compounds
  • Indoles
  • Isopropyl esters
  • Kinase inhibitors
  • Orphan drugs
  • Pyrimidines
  • Tertiary amines

Keep exploring